This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

Clinical trial NCT06451497 · RECRUITING

Trial details

NCT number: NCT06451497
Sponsor: Zumutor Biologics Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Head and Neck Squamous Cell Carcinoma Pancreas Adenocarcinoma Biliary Tract Cancer Prostate Cancer Urothelial Carcinoma Colorectal Cancer Triple Negative Breast Cancer High Grade Ovarian Serous Adenocarcinoma Diffuse Large B Cell Lymphoma Renal Cell Cancer Metastatic

Start date: 2024-05-22
Primary completion: 2026-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.